Cleveland, Ohio 44195


Purpose:

The purpose of this study is to discover genes that may cause Coronary Artery Disease (CAD) or Arteriovenous Malformation (AVM).


Study summary:

The purpose of this study is to discover genes that may cause Coronary Artery Disease (CAD) or Arteriovenous Malformation (AVM). Many human diseases are inherited or passed from parent to child in families. These diseases occur because of damage to a gene(s), the genetic material that is also called DNA. Scientists can now use modern molecular techniques to locate and to find certain genes within the DNA (genetic material) of a person, and to follow their inheritance in a family. To find these disease-causing genes requires studies of many affected with the disease and their family members. The purpose of this study is to locate and to find the genes for coronary artery disease (CAD) which occurs when one or more of the arteries that carry oxygen-rich blood from your heart to the rest of your body develop blockages; or, arteriovenous malformation (AVM) which causes abnormal vascular connections between arteries and veins, particularly near the heart. Findings of the genes causing CAD and AVM will have far-reaching effect on the diagnosis, treatment, and prevention of coronary artery disease and arteriovenous malformation. These studies will lead to possible genetic diagnosis, early detection of persons at risk for developing CAD or AVM (even in the absence of symptoms), development of effective drugs, more rational and specific therapeutic interventions, treatments and ultimately, prevention of coronary heart disease. Approximately 3-5 years are required to find one human disease gene.


Criteria:

Inclusion Criteria: - Males at least 45 years old and premenopausal females at least 50 years old at the time of onset of any of the following: - PTCA - MI - CABG - Must have a living sibling meeting the same criteria. Exclusion Criteria: - Substance Abuse in the absence of angiographic coronary stenosis - Congenital Heart Disease


NCT ID:

NCT00590291


Primary Contact:

Principal Investigator
Qing Wang, PhD
The Cleveland Clinic

Rajani Tendulkar, MHA
Phone: 216-444-0251
Email: tendulr2@ccf.org


Backup Contact:

Email: wangq2@ccf.org
Qing Wang
Phone: 216-445-0570


Location Contact:

Cleveland, Ohio 44195
United States

Qing Wang
Phone: 216-445-0570
Email: wangq2@ccf.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.